Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
JUPITER, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Alphazyme, a manufacturer of molecular biology enzymes, has been awarded certification to the ISO 13485:2016 Quality Management System (QMS) standard...
-
BARCELONA, Spain, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Centre for Research in Agricultural Genomics (CRAG) and the Institute of Agriculture and Food Research and Technology (IRTA) have expanded...
-
STAMFORD, Conn., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, has collaborated on research debunking a commonly held belief that exome and genome sequencing...
-
STAMFORD, Conn., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced it is a partner in the recently launched GUARDIAN study (Genomic Uniform-screening...
-
MADRID, Spain, Oct. 03, 2022 (GLOBE NEWSWIRE) -- AM FRESH Group, a leading global company in genetics, agri-tech and farming has acquired a majority stake in Asian-based Fruit-X to redefine the...
-
WASHINGTON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Today, the Chan Zuckerberg Initiative (CZI) announced a partnership with Howard University and the nation’s three other historically Black medical...
-
New York, USA, Aug. 23, 2022 (GLOBE NEWSWIRE) -- The global pharmacogenomics market is expected to grow due to the constantly rising need for treating fatal diseases like cancer and increasing...
-
Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad’s commitment to growing international lab partner program SALT LAKE CITY, Aug....
-
New York, June 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service...
-
STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate...